• 07 Oct 25
 

Insig AI Plc - Equity fundraise


Insig AI PLC | INSG | 31.5 -1.5 (-4.5%) | Mkt Cap: 38.3m



RNS Number : 2833C
Insig AI Plc
07 October 2025
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) NO. 596/2014. It forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this information is considered to be in the public domain.

 

Insig AI plc

("Insig AI", the "Company" or the "Group")

 

 

Equity fundraise

 

Insig AI plc (AIM:INSG), a provider of AI-led analytics and machine learning solutions is pleased to announce that following receipt of an unsolicited offer of equity investment, it has raised gross proceeds of approximately £500,000 at 30p per ordinary share of 1 pence each ("Ordinary Share") (the "Placing").  The placing price represents a discount of 7.41% to the closing share price on 6 October 2025 of 32.4p. The Placing proceeds will be used for general working capital purposes including bolstering Insig's sales activities and the continuing evaluation of the Company's strategic options including the potential establishment of a fund dedicated to investments in digital assets and related enterprises. The Placing will be satisfied by the issue of 1,666,666 Ordinary Shares (the "Placing Shares"). CMC Markets UK Plc ("CMC"), trading as CapX, acted as the Company's sole placing agent in respect of the Placing.

 

 

Insig AI is also pleased to report that unaudited revenues for the six months to 30 September 2025 were circa £421k, more than 155% ahead of the equivalent period last year (£165k). This represents a further acceleration from the three months to 30 June 2025, where comparable sales growth was 143%.  

 

Insig AI is also pleased to announce that CMC has been appointed as the Company's joint corporate broker.

 

Admission and Total Voting Rights

 

Application will be made to the London Stock Exchange for admission of the Placing Shares to trading on AIM ("Admission"). Admission is expected to become effective, and dealings in the Subscription Shares are anticipated to commence on or around 13 October 2025.

 

Following Admission, the issued share capital and total voting rights of the Company will be 123,349,309. Shareholders may use this figure as the denominator to determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Richard Bernstein, Chief Executive commented: "We're pleased to have attracted this offer of equity capital. It enables us to allocate further resource towards the evaluation of strategic options including the potential establishment of a fund dedicated to digital assets and related enterprises as well as being able to invest for additional sales growth from our current and planned new product offerings. Furthermore, with these various initiatives and evaluations taking shape, now is the time to have CMC Markets, with its impressive reach and market positioning, as our joint broker."

 

 

For further information, please visit www.insig-ai.com or contact:

 

Insig AI plc

Richard Bernstein, CEO                                                                    

richard.bernstein@insg.ai

 

Zeus (Nominated Adviser & Joint Broker)     

David Foreman / James Hornigold

                    +44 (0) 203 829 5000

 

CMC Markets (Joint Broker)

Douglas Crippen                                                                                                                + 44 (0) 203 003 8632

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEEAFEKEEASFAA